Home > Press > Advance Nanotech Retains ROI Group LLC as Investor Relations Counsel
Advance Nanotech Inc. (OTC BB: AVNA), the premier provider of financing and support services to drive the commercialization of nanotechnology related products for homeland security and display technologies, announced today that it has retained ROI Group LLC as its investor relations counsel. ROI will be executing a comprehensive investor outreach program on behalf of AVNA, introducing AVNA's compelling investment story to a diverse audience of potential investors.
Advance Nanotech Retains ROI Group LLC as Investor Relations Counsel
New York, NY | Posted on March 12th, 2007
"We have spent the past 4 years developing interests in over 20 nanotechnologies, with many of them positioned for commercialization over the coming few years. Our ability to create and drive innovative nanotechnologies is well-established, and we look forward to harvesting the benefits of our investments over the coming years. Investors are keenly interested in nanotechnologies and appreciate the enormous potential for them to impact our daily lives," said Tony Goncalves, CEO of Advance Nanotech. "In hiring ROI, we are continuing to expand our efforts to communicate our compelling story to an increasingly large audience of potential shareholders. Our long-term commitment to creating shareholder value will be aided by ROI's expertise in working with emerging growth companies such as ours," concluded Mr. Goncalves.
Robert Giordano, Managing Director of ROI Group LLC, commented, "Advance Nanotech is an exceptional growth opportunity in our estimation. Advance Nanotech's diverse portfolio of nanotechnologies creates a strong story for us to introduce to potential shareholders. While the nanotechnology space has been cyclical in valuation, we believe that Advance Nanotech's approach is very attractive. By collaborating with some of the world's most prestigious universities, Advance Nanotech is building a solid foundation for future growth. We are excited about working with Advance Nanotech management in building their company."
About Advance Nanotech
Advance Nanotech identifies patented, patent-pending and proprietary technologies at leading universities and funds the additional development of such technologies in exchange for the exclusive rights to commercialize any resulting products. Advance Nanotech has interests in over 20 nanotechnologies which are grouped into two operating subsidiaries: Advance Display Technologies plc, which is listed on the PLUS-Quoted market in London (ADTP) and Advance Homeland Security plc.
By partnering with universities and leveraging the infrastructure and multi-disciplinary human resources of our university partners, we reduce our cost base and mitigate risk. After prototypes are proven within the lab and we develop a product roadmap and business plan, we form majority owned subsidiaries around the specific technology. We seek to return value to our shareholders through the sale or licensing of the technology, by securing additional financing for the subsidiary from either the venture capital community or the capital markets, or by successfully executing our business plan and consolidating its income as the majority shareholder.
This news release contains forward-looking statements within the meaning of the "safe harbour" provisions of the Private Securities Litigation Reform Act of 1995. These statements are based upon our current expectations and speak only as of the date hereof. Our actual results may differ materially and adversely from those expressed in any forward-looking statements as a result of various factors and uncertainties, including the recent economic slowdown affecting technology companies, the future success of our scientific studies, our ability to successfully develop products, rapid technological change in our markets, changes in demand for our future products, legislative, regulatory and competitive developments and general economic conditions. Our Annual Report on Form 10-K and 10-K/A, recent and forthcoming Quarterly Reports on Form 10-Q and 10-Q/A, recent Current Reports and other SEC filings discuss some of the important risk factors that may affect our business, results of operations and financial condition. We undertake no obligation to revise or update publicly any forward-looking statements for any reason.
For more information, please click here
ROI Group Associates, Inc.
Robert Giordano, 212-495-0201
Copyright © Business Wire
If you have a comment, please Contact
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Malaysian Nanotechnology Company Nanopac Innovation Ltd. lists on the NSX January 19th, 2015
Aspen Aerogels, Inc. to Present at the Needham Growth Conference January 8th, 2015
Blend Therapeutics Secures $21 Million Financing and Unveils Novel Pentarin™ Platform for Cancer Therapeutics: Company’s Technology and Expertise in Cancer R&D Evolve to Create New Class of Miniaturized Biologic Drug Conjugates (mBDCs) Encapsulated in Nanoparticles January 8th, 2015
Nanometrics to Announce Fourth Quarter and Full Year Financial Results on February 2, 2015 January 7th, 2015
Iranian Researchers Planning to Produce Edible Insulin January 28th, 2015
Nanoparticles that deliver oligonucleotide drugs into cells described in Nucleic Acid Therapeutics January 28th, 2015
'Bulletproof' battery: Kevlar membrane for safer, thinner lithium rechargeables January 28th, 2015
Spider electro-combs its sticky nano-filaments January 28th, 2015
Rice's Naomi Halas to direct Smalley Institute: Optics pioneer will lead Rice's multidisciplinary science institute January 15th, 2015
SUNY Board Appoints Dr. Alain Kaloyeros as Founding President of SUNY Polytechnic Institute January 13th, 2015
Blend Therapeutics Appoints Distinguished Physician Scientist, Dennis Ausiello, MD, to Board of Directors January 8th, 2015
QD Vision Receives New Funding Round to Meet Growing Demand for Quantum Dot Technology: Industry Veteran Steve Ward Named Executive Chairman January 5th, 2015